Semax
🔬 Overview
Semax is a synthetic heptapeptide derived from a fragment of ACTH, studied in Russia for cognition, focus, and neuroprotection. It is often researched for its reported effects on BDNF, a protein involved in neuron growth.
It is commonly studied alongside selank, a related research peptide with a calming rather than stimulating profile.
💉 Research-Reported Dosing
| Protocol | Dose | Frequency | Notes |
|---|---|---|---|
| Lower research | 200-300 mcg | Once or twice daily | Introductory range |
| Common research | 300-600 mcg | Daily, split | Frequently cited |
| Route | Intranasal or SC | Daily | Intranasal is common |
Figures are drawn from research literature and community protocols. They are not dosing recommendations. Use the dosage calculator to convert any amount into a syringe volume.
⚗️ Reconstitution & Solubility
- Bring vial and diluent to room temperature
- Swab stoppers and let dry
- Add bacteriostatic water (injection) or sterile saline (intranasal) down the vial wall
- Swirl gently until clear
- Refrigerate at 2 to 8 C after reconstitution
📍 Administration
Studied both as an intranasal solution and as subcutaneous injection. Intranasal is the traditional research route. Convert injectable amounts with the calculator.
📚 Research Notes
Russian research has examined semax for cognition, stroke recovery, and attention. It is reported to influence BDNF and the dopaminergic and serotonergic systems. Western clinical data is limited.
⚠️ Safety & Disclaimer
Semax is a research compound and is not approved for human use in most countries. This is not medical advice. Handle as a research chemical only.